Market research

300871.SHE Hvsen Biotechnology Co., Ltd

SHE CNY Healthcare

Latest close

— —

Loading market data…

Test a moving-average rule with historical data.

Market facts

Market cap: 4B
P/E ratio: 12.74
Analyst target: 17.89
Dividend yield: 2.3%
Beta: 0.59

Loading price history…

Profile

Company facts

Exchange: SHE
Currency: CNY
Sector: Healthcare
Industry: Biotechnology
ISIN: CNE1000047H6
Market cap: 4B
P/E ratio: 12.74
Analyst target: 17.89
Dividend yield: 2.3%
Beta: 0.59

About

About Hvsen Biotechnology Co., Ltd

Wuhan Hvsen Biotechnology Co.,Ltd. is involved in the research and development, and manufacture of macrolides APIs and preparations in China and internationally. The company provides tylvalosin tartrate powders, and raw materials; florfenicol, cefquinome sulfate, and tildipirosin injections; and florfenicol powder/WSP, tylosin tartrate soluble powder, and tywasin premix products, as well as Tildipirosin. It produces various veterinary drug products of raw materials and preparations, as well as traditional Chinese medicines extractives. Hvsen Biotechnology Co., Ltd. was founded in 2002 and is based in Wuhan, China.

Visit company website

Reported results

Fundamentals

Open this section to load reported financial history.

Annual returns

No comments yet

Start a focused discussion about 300871.SHE.

300871.SHE Hvsen Biotechnology Co., Ltd

Price & volume

Company facts

About Hvsen Biotechnology Co., Ltd

Fundamentals

Earnings

Cash flow

Profitability

Valuation

Performance

Annual returns

Investor discussion

No comments yet